Loading…
Maximum tumor diameter and renal function can predict the declining surface dose rate after 177 Lu-Dotatate: preliminary results of single institution in Japan
This study aimed to develop a user-friendly prediction formula for dose rate adjustment after initial Lu-Dotatate therapy from a prospective observational study of patients. This study included consenting patients in a prospective observational study who underwent their first treatment in four cycle...
Saved in:
Published in: | Japanese journal of radiology 2024-09, Vol.42 (9), p.1031 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | This study aimed to develop a user-friendly prediction formula for dose rate adjustment after initial
Lu-Dotatate therapy from a prospective observational study of patients.
This study included consenting patients in a prospective observational study who underwent their first treatment in four cycles of
Lu-Dotatate treatment at our hospital between January 2022 and February 2024. All patients received 7.4 GBq of
Lu-Dotatate. The prediction formula was derived from the regression analysis of tumor-related factors and renal function. Creatinine clearance was estimated using the Cockcroft-Gault equation in this study for renal function.
Among the 13 patients (seven males, six females, median age: 59 years), logarithmically transformed total tumor volume (cc) and maximum tumor diameter (mm) of primary tumors or metastases showed strong correlations (p |
---|---|
ISSN: | 1867-108X |